Wednesday 10 May, 11:05 AM - 11:35 AM
Latest Clinical Evidences supporting the Use of Pylopass™ for Gastric Health
Probiotics Resource Centre
Pylopass contains a patented Lactobacillus reuteri strain that has been selected through a multi-year screening in order to restore the gastric microflora. Pylopass specifically binds with Helicobacter pylori in the stomach, and the resulting health benefits have been proven in five published clinical studies. This innovative gastric health ingredient has been launched by leading dietary supplements companies in the Americas, Europe and Asia.
Speakers

Speakers
20775